RDCM
name pending profile ingest
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +30.0% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 28 | +1 | 1.35M | $19.10M | +3 | −2 |
| Q1 2026 | 27 | +2 | 1.19M | $14.43M | +5 | −3 |
| Q4 2025 | 25 | +2 | 1.39M | $18.13M | +2 | — |
| Q3 2025 | 10 | -1 | 714.97K | $10.36M | — | −1 |
| Q2 2025 | 8 | +2 | 673.38K | $9.15M | +2 | — |
| Q1 2025 | 5 | 0 | 476.33K | $5.44M | +1 | −1 |
| Q4 2024 | 5 | 0 | 399.81K | $4.94M | — | — |
| Q3 2024 | 5 | +2 | 305.79K | $3.16M | +2 | — |
| Q2 2024 | 3 | — | 216.44K | $2.02M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Renaissance Technologies ✦ | 238.23K | +8.5% | $2.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 2 | Millennium Management ✦ | 57.51K | +171.6% | $710,762 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Marshall Wace ✦ | 51.33K | +61.0% | $634,376 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Marshall Wace ✦ | 51.33K | +61.0% | $634,376 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 39.08K | +101.2% | $483,066 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 39.08K | +101.2% | $483,066 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 13.67K | 0.0% | $168,936 | 0.0% | Held | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 43 holders, 8.47M shares, $91.40M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.